Syndax Pharmaceuticals, Inc.
Status: Publicly traded
Direct answer
Syndax Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker SNDX.
Syndax Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm focused on developing innovative therapies for cancer. Among its leading investigational products are SNDX-5613, currently undergoing Phase 1/2 clinical assessment, which targets the Menin-mixed lineage leukemia 1 protein interaction for treating MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML)....
Can you invest in Syndax Pharmaceuticals, Inc.?
Yes. Syndax Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker SNDX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Syndax Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.